Bacillus Calmette-Guérin Plus Mitomycin Versus Bacillus Calmette-Guérin Alone for Bacillus Calmette-Guérin–naïve Non–muscle-invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301)

Dickon Hayne, Alison Y. Zhang, Hayley Thomas, Laurence Krieger, Joseph Ischia, Paul Anderson, Ratnesh K. Srivastav, William Green, Jeremy Grummet, Patricia A. Bastick, Emma K. Beardsley, Alison Blatt, Manish Patel, Lewis Chan, Andrew Mitterdorfer, Matthew Roberts, Shomik Sengupta, Matthew Winter, Gavin Marx, Conrad Bishop, Leanna Cheung, Cynthia Hawks, Andrew Martin, Steve P. McCombie, Andrew D. Redfern, Ian D. Davis, Martin R. Stockler

Open source

DOI
10.1016/j.eururo.2026.01.009
Published
2026-05
Container
European Urology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.eururo.2026.01.009,
  title = {Bacillus Calmette-Guérin Plus Mitomycin Versus Bacillus Calmette-Guérin Alone for Bacillus Calmette-Guérin–naïve Non–muscle-invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301)},
  author = {Dickon Hayne and Alison Y. Zhang and Hayley Thomas and Laurence Krieger and Joseph Ischia and Paul Anderson and Ratnesh K. Srivastav and William Green and Jeremy Grummet and Patricia A. Bastick and Emma K. Beardsley and Alison Blatt and Manish Patel and Lewis Chan and Andrew Mitterdorfer and Matthew Roberts and Shomik Sengupta and Matthew Winter and Gavin Marx and Conrad Bishop and Leanna Cheung and Cynthia Hawks and Andrew Martin and Steve P. McCombie and Andrew D. Redfern and Ian D. Davis and Martin R. Stockler},
  year = {2026},
  journal = {European Urology},
  doi = {10.1016/j.eururo.2026.01.009},
  url = {https://doi.org/10.1016/j.eururo.2026.01.009}
}

RIS

TY  - JOUR
TI  - Bacillus Calmette-Guérin Plus Mitomycin Versus Bacillus Calmette-Guérin Alone for Bacillus Calmette-Guérin–naïve Non–muscle-invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301)
AU  - Dickon Hayne
AU  - Alison Y. Zhang
AU  - Hayley Thomas
AU  - Laurence Krieger
AU  - Joseph Ischia
AU  - Paul Anderson
AU  - Ratnesh K. Srivastav
AU  - William Green
AU  - Jeremy Grummet
AU  - Patricia A. Bastick
AU  - Emma K. Beardsley
AU  - Alison Blatt
AU  - Manish Patel
AU  - Lewis Chan
AU  - Andrew Mitterdorfer
AU  - Matthew Roberts
AU  - Shomik Sengupta
AU  - Matthew Winter
AU  - Gavin Marx
AU  - Conrad Bishop
AU  - Leanna Cheung
AU  - Cynthia Hawks
AU  - Andrew Martin
AU  - Steve P. McCombie
AU  - Andrew D. Redfern
AU  - Ian D. Davis
AU  - Martin R. Stockler
PY  - 2026
JO  - European Urology
DO  - 10.1016/j.eururo.2026.01.009
UR  - https://doi.org/10.1016/j.eururo.2026.01.009
ER  - 

APA

Hayne, D., Zhang, A. Y., Thomas, H., Krieger, L., Ischia, J., Anderson, P., Srivastav, R. K., Green, W., Grummet, J., Bastick, P. A., Beardsley, E. K., Blatt, A., Patel, M., Chan, L., Mitterdorfer, A., Roberts, M., Sengupta, S., Winter, M., Marx, G., Bishop, C., Cheung, L., Hawks, C., Martin, A., McCombie, S. P., Redfern, A. D., Davis, I. D., & Stockler, M. R. (2026). Bacillus Calmette-Guérin Plus Mitomycin Versus Bacillus Calmette-Guérin Alone for Bacillus Calmette-Guérin–naïve Non–muscle-invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301). European Urology. https://doi.org/10.1016/j.eururo.2026.01.009

Source records